shaunak amin

Alembic Pharmaceuticals experienced a 12.1% dip in Q4 net profit, reaching Rs 156.63 crore, despite a 16.7% surge in revenue to Rs 1,769.64 crore. While India formulations and US revenue showed growth, the company's full-year revenue increased by 7% to Rs 6,672 crore. Despite the profit decline, the company remains optimistic about sustained growth across various segments.

A new type of fair was held in the city on Sunday where the citizens of Vadodara bought items with the knowledge that their generosity was being used to educate underprivileged children, and that too for only ten rupees.

Alembic Pharmaceuticals on Friday reported 8.05 per cent rise in consolidated net profit to Rs 69.88 crore for the first quarter ended June 30, 2015-16, mainly on account of robust sales.